Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Merrimack Pharmaceuticals Inc (MACK)

NASDAQ: Health Care

Get a 5-page Ratings Report on (MACK) now
$5.28 -0.24 | -4.35%
Today's Range: 5.27 - 5.66
MACK Avg. Daily Volume: 328,100
05/20/13 - 4:00 PM ET
Company Cash Flow
Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -91.75M -79.68M -50.16M
Operating Gains/Losses 0.00 864.00K -130.00K
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.84M -3.68M -1.98M
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets -2.35M 0.00 0.00
(Decrease) Increase In Payables 6.98M 3.22M -830.00K
(Decrease) Increase In Other Current Liabilities 0.00 5.60M 1.02M
(Increase) Decrease In Other Working Capital 1.58M 13.25M 14.42M
Other Non-Cash Items 6.38M 6.95M 8.22M
Net Cash From Continuing Operations -79.82M -52.82M -26.37M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -79.82M -52.82M -26.37M
Sale of Property, Plant & Equipment 0.00 0.00 26.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -3.19M -3.75M -5.02M
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00
Other Cash from Investing Activities -247.00K 7.00K 99.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -75.22M -3.75M -4.90M
Issuance of Debt 41.13M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 105.45M 78.69M 4.46M
Repayment of Long-Term Debt -48.00K -443.00K -864.00K
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends -4.24M 0.00 0.00
Other Financing Charges, Net 0.00 -1.95M 0.00
Net Cash From Financing Activities 142.30M 76.30M 3.60M
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -12.74M 19.74M -27.67M
(MACK) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,335.28 -19.12 -0.12%
NASDAQ 3,496.43 -2.54 -0.07%
S&P 500 1,666.29 -1.18 -0.07%
US 10 Yr 1.965% +0.016

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs